Home Recurrent Condylomata Acuminata in a Transplant Patient
Article Publicly Available

Recurrent Condylomata Acuminata in a Transplant Patient

  • Ritchie Delara , Longwen Chen , Tonia Young-Fadok and Megan Wasson
Published/Copyright: October 1, 2020

A 49-year-old woman presented with recurrent vulvar and perianal condyloma for 1 year (image A). Her medical history included deceased donor renal transplant. She was taking 500 mg of mycophenolate orally twice per day and 2 mg of tracrolimus orally twice per day for immunosuppressive therapy. She had prior wide local excision of bilateral vulva with laser fulguration of a condyloma and subsequent trichloroacetic acid ablation. An anal Papanicolaou test was positive for low-grade squamous intraepithelial lesion (image B). Vulvar and anorectal condyloma excision was performed (image C and image D). Vulvar condylomas were negative for dysplasia and high-risk human papillomavirus. Perianal condylomas were positive for squamous cell carcinoma in situ and positive for (other high-risk) human papillomavirus (image E).

Women who are immunosuppressed and aged 40 years or older with a history of vulvar or cervical dysplasia have an increased risk for anogenital cancer.1-5 Abnormal cytologic findings should prompt high-resolution anoscopy or referral to colorectal surgery.1,3 When managing benign conditions like vulvar condylomas, gynecologists should strongly consider anal cancer screening using history, examination, and anal cytology with cotesting.


From the Department of Gynecologic Surgery (Drs Delara and Wassoon); the Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology (Dr Chen); and the Division of Colon and Rectal Surgery, Department of Surgery (Dr Young-Fadok) at the Mayo Clinic in Phoenix, Arizona.
Financial Disclosures: None reported.
Support: None reported.

*Address correspondence to Ritchie Delara, MD, 5777 E Mayo Blvd, Phoenix, AZ 85054. Email:


References

1. MoscickiAB, DarraghTM, Berry-LawhornJM, et al.. Screening for anal cancer in women. J Low Genit Tract Dis.2015;19(3 suppl 1):S27-542. doi:10.1097.LGT0000000000000117Search in Google Scholar

2. NadhanKS, LarijaniM, AbbottJ, DoyleAM, LinfanteAW, ChungCL. Prevalence and types of genital lesions in organ transplant recipients. JAMA Dermatol.2018;154(3):323-329. doi:10.1001/jamadermatol.2017.5801Search in Google Scholar PubMed PubMed Central

3. StierEA, SebringMC, MendezAE, BaFS, TrimbleDD, ChiaoEY. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review. Am J Obstet Gynecol. 2015;213(3):278-309. doi:10.1016/jajog.2015.03.034.Search in Google Scholar

4. VeguntaS, FilesJA, WassonMN. Screening women at high risk for cervical cancer: special groups of women who require more rrequent screening. Mayo Clin Proc. 2017;92(8):1272-1277. doi:10.1016/j.mayocp.2017.06.007Search in Google Scholar PubMed

5. WorkowskiKA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015 [published correction appears in MMWR Recomm Rep. 2015;64(33):924]. 2015;64(RR-03):1-137. MMWR Recomm Rep. 2015;64(RR-03):1-137.Search in Google Scholar

Received: 2020-02-22
Accepted: 2020-02-28
Published Online: 2020-10-01
Published in Print: 2020-10-01

© 2020 American Osteopathic Association

Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2020.126/html
Scroll to top button